Hoplite Capital Management’s Allergan plc AGN Stock Holding History

Hoplite Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-359,300	Closed	-$83M	–	42
2016 Q2	$83M	Buy	359,300 +59,475	+20%	+$13.7M	4.11%	11
2016 Q1	$80.4M	Sell	299,825 -313,399	-51%	-$89.7M	4.06%	11
2015 Q4	$192M	Sell	613,224 -254,606	-29%	-$75.8M	8.31%	3
2015 Q3	$236M	Buy	867,830 +19,068	+2%	+$5.86M	8.92%	1
2015 Q2	$258M	Sell	848,762 -25,968	-3%	-$7.75M	6.9%	1
2015 Q1	$260M	Sell	874,730 -83,601	-9%	-$23.8M	8.03%	1
2014 Q4	$247M	Hold	958,331	–	–	6.83%	2
2014 Q3	$231M	Hold	958,331	–	–	5.9%	1
2014 Q2	$214M	Buy	958,331 +74,744	+8%	+$15.5M	5.51%	2
2014 Q1	$182M	Sell	883,587 -573,272	-39%	-$114M	5.02%	2
2013 Q4	$245M	Buy	1,456,859 +583,683	+67%	+$91.2M	6.88%	1
2013 Q3	$126M	Buy	+873,176	New	+$116M	4.47%	8

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Hoplite Capital Management's AGN Position: Q3 2016 in Review

Hoplite Capital Management sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 359,300 shares — an estimated $83M sold.

Hoplite Capital Management first reported a position in AGN in Q3 2013 and held it in 12 quarters. The position peaked at $260M in Q1 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

Hoplite Capital Management reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
Hoplite Capital Management sold 359,300 Allergan plc shares in Q3 2016, an estimated $83M.
Hoplite Capital Management first reported a position in Allergan plc in Q3 2013 and held it in 12 quarters.
Hoplite Capital Management's Allergan plc position peaked at $260M in Q1 2015.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Hoplite Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.